EnVVeno Medical Corporation
NVNO
Rank in Stocks
#30644
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Share Price
$6.85
Last synced: 2026-11-09
Market Cap
$4.76M
Change (1 day)
1.78%
Change (1 year)
-72.20%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade EnVVeno Medical Corporation (NVNO)
Category
Healthcare
Operating Margin for EnVVeno Medical Corporation (NVNO)
Operating Margin as of November 2026 TTM: 0.00%
According to EnVVeno Medical Corporation's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for EnVVeno Medical Corporation from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | -24,566.50% | 483.46% |
| 2018 | -4,210.51% | 191.21% |
| 2017 | -1,445.89% | 143.89% |
| 2016 | -592.84% | 0.00% |
| 2015 | 0.00% | -100.00% |
| 2014 | -402.82% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | - |
US
|
|
| 18.08% | - |
IE
|
|
| 21.25% | - |
US
|
|
| 21.05% | - |
US
|
|
| 28.09% | - |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about EnVVeno Medical Corporation's operating margin
What was EnVVeno Medical Corporation's operating margin in 2025?
In 2025, EnVVeno Medical Corporation's operating margin was 0.00%, compared with 0.00% in 2024.
How has EnVVeno Medical Corporation's operating margin changed since 2020?
From 2020 to 2025, EnVVeno Medical Corporation's operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does EnVVeno Medical Corporation's operating margin compare with similar companies?
EnVVeno Medical Corporation's operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.